CompletedPhase 3NCT00885365
A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®
Studying Body integrity dysphoria
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Principal Investigator
- Henryk Mazurek, DoctorKlinika Pneumonologii i Mukowiscydozy, Instytut Gruzlicy i Chorob Pluc w Rabce Zdroj
- Intervention
- tobramycin / Bramitob(drug)
- Enrollment
- 324 enrolled
- Eligibility
- 6 years · All sexes
- Timeline
- 2009 – 2010
Study locations (30)
- Centrum pro cystickou fibrosu, Pediatricka klinika UK 2.LF, Fakultní nemocnice v Motole, Prague, Czechia
- CHR Clemenceau, Caen, France
- Hopital Arnaud de Villeneuve, Clinique des maladies respiratoires, Montpellier, France
- Hopital Necker, Paris, France
- Pädiatrische Pneumologie und Allergologie, Mukovizidose-Zentrum, Zentrum für Kinderheilkunde und Jugendmedizin, GieBen, Germany
- HELIOS Klinikum Krefeld, Zentrum für Kinder- und Jugendmedizin, Krefeld, Germany
- Fővárosi Önkormányzat Heim Pál, Budapest, Hungary
- Kaposi Mór Oktatókórház, Mosdós, Hungary
- Szegedi Tudományegyetem Szent-Györgyi Albert Orvos- és Gyógyszerésztudományi Centrum, Szeged, Hungary
- Specjalistyczny ZOZ nad Matka i Dzieckiem, Poradnia Leczenia Mukowiscydozy, Gdansk, Poland
- I Oddzial Chorob Dzieciecych, Wojewodzki Specjalistyczny Szpital Dzieciecy, Kielce, Poland
- Oddzial Kliniczny Interny Dzieciecej i Alergologii, Wojewodzki Szpital Specjalistyczny, Lodz, Poland
- Dzieciecy Szpital Kliniczny Akademii Medycznej, Klinika Chorob Pluc I Reumatologii, Lublin, Poland
- Multiple Locations, Poland
- Klinika Pneumonologii, Alergologii Dzieciecej i Immunologii Klinicznej Szpital Kliniczny Uniwersytetu Medycznego w Poznaniu, Poznan, Poland
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00885365 on ClinicalTrials.govOther trials for Body integrity dysphoria
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06898905Hyperfractionated Dual Equivalent Fractionated Radiation TherapyYale University
- RECRUITINGPHASE1NCT06966388Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing RadiationVirginia Commonwealth University
- RECRUITINGPHASE1, PHASE2NCT06853015Double Dose 4-AP on Functional Recovery After Spinal Cord InjuryShirley Ryan AbilityLab
- ACTIVE NOT RECRUITINGPHASE3NCT05456425A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With PterygiumCloudbreak Therapeutics, LLC